Navigation Links
NHLBI issues first US von Willebrand Disease clinical practice guidelines
Date:2/29/2008

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, today issued the first clinical guidelines in the United States for the diagnosis and management of von Willebrand Disease (VWD), the most common inherited bleeding disorder. The guidelines include recommendations on screening, diagnosis, disease management, and directions for future research. An extensive article on the guidelines is published online Feb. 29 in the journal Haemophilia.

In VWD, low or absent levels of a blood protein called von Willebrand factor affect the bloods ability to clot. Von Willebrand factor also carries with it clotting factor VIII, another important protein that helps blood clot. VWD is typically milder but more common than another bleeding disorder, hemophilia. However, for some people with VWD, the condition can pose serious health risks, especially during surgery, following an injury, or during childbirth. VWD affects 1 out of every 100 to 1,000 people - both males and females. Hemophilia mainly affects males.

These are the first guidelines on von Willebrand Disease published in the United States and we are pleased to offer clinicians science-based recommendations in the evaluation and treatment of patients, said NHLBI Director Elizabeth G. Nabel, M.D. The disease can be difficult to diagnose, especially in women of child-bearing age and in children, and the danger of excessive bleeding is often under-recognized.

In consultation with the American Society of Hematology, the NHLBI convened an expert panel on VWD whose members were selected for their scientific and clinical knowledge and experience, including specialists in hematology as well as family medicine, obstetrics and gynecology, pediatrics, internal medicine, and laboratory sciences. A draft of the guidelines was posted on the NHLBI Website for a 30-day public comment period in September 2006.

Screening recommendations in the guidelines cal
'/>"/>

Contact: NHLBI Communications Office
NHLBI_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
2. 200 journals join in theme issues on poverty and human development
3. Knocking out cell receptor may help block fat deposits in tissues, prevent weight gain
4. Media highlights in the November issues of Biophysical Journal
5. Media highlights in the January issues of Biophysical Journal
6. NAS to hold 2-day summit on energy issues
7. Which came first, the moth or the cactus?
8. First all-African GM crop is resistant to maize streak virus
9. Scientists retrace evolution with first atomic structure of an ancient protein
10. CU-Boulder team discovers first ancient manioc fields in Americas
11. First finding of a metabolite in 1 sex only

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...t a common oral bacterium may exacerbate autoimmun...Unique Lipids from a Common Human Bacterium Repres...ng Autoimmunity," appears in the December 2009 iss...tiple sclerosis (MS), a disease where the immune s...early 1 in 700 people in the United States. Patie...
(Date:11/23/2009)...highest resolution images of peptides attaching to...tanding how biomolecules manipulate the growth cry...or kidney stones using biomolecules. , The resea...f the journal Proceedings of the National Academy... mineral surfaces by accelerating, switching and i...
(Date:11/23/2009)...icrobiologist Louis Tisa has received two grants t...ctinorhizal plants, widespread woody plants with p...soils. , The United States Department of Agricu...r, cellular and biomedical sciences, $399,000 to e...eria Frankia and Casuarina, an actinorhizal plant....
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 1Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 2Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 1Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 2Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference 48033 1
...on evolution will gather in Minnesota June 20 thro...nnual gathering of evolutionary biologists. The co...ntists to share research related to evolution, is ...seum of Natural History, the university,s College ...Science Education. , Headlining the event is Oliv...
...ounded evolutionary biologists since Charles Darwi...e parasites depend on their hosts for survival, wh...a and Emory University study of monarch butterflie...on them finds that the parasites strike a middle g...apidly and the costs to their hosts. The study, pu...
...holtz Centre for Environmental Research (UFZ) in L...(Caltech) in Pasadena succeeded in capturing syntr...at are known to dramatically reduce the oceanic em...organisms that oxidize methane anaerobically are a...nd a major sink for methane on Earth. Methane -- a...
Other Biology News:University of Minnesota to host world's largest conference on evolution 2Monarch butterflies help explain why parasites harm hosts 2Monarch butterflies help explain why parasites harm hosts 3Deep sea methane scavengers captured 2Deep sea methane scavengers captured 3
(Date:11/24/2009)...able in German . , Whether it,s CD packagin...Radio Frequency Identification) are increasingly f...possible to label objects or goods and identify th...te scanner can read and process the data contained...s under production conditions of up to 100 degrees...
(Date:11/24/2009)...,Nov.24/PRNewswire/--Twomoreprestigiousuniversitie...ejobboardandcareerssiteforlifescienceprofessionals...bersofthejobboard,joining28othermajorlifesciencetr...ercenter.com ,isonlyforpost-graduatesinthelifescie...ontheInternet,BioCareerCenteristheonlyonethatserve...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
(Date:11/24/2009)...PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chin...edthe,investigationalnewdrugapplication(IND)forits...mulationtotreatdiabetes.ThisIND,approvalallowsBiol...iabetesisadisordercharacteristicofhighbloodglucose...resultinseveremicro-and,macro-vasculardiseases,los...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...urocrine Biosciences,Inc. (Nasdaq: NBIX ) announc...loyees at its San Diego campus, as a part of its r...d development programs and associated costs,and ex...ese reductions,Neurocrine will have approximately ...that we have to make this difficult,decision that ...
... Martek Biosciences,Corporation announced today t...icense and supply agreement for infant formula wit...harmaceutical. Under the terms of the,agreement, M... all IlDong,Foodis infant formula products in Sout...at contain the long-chain,polyunsaturated fatty ac...
...he US Oncology Adjuvant Trial 9735 at 2007 San, A...and Cyclophosphamide Improved Overall Survival..., Dec. 13 Results presented at the,30th annual Sa...hat for,women with early stage breast cancer who h...l chemotherapy combination of Taxotere(R) (docetax...
Other Biology Technology:Neurocrine Announces Work Force Restructuring 2Neurocrine Announces Work Force Restructuring 3Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 2Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5
Mouse Anti-MMP-20 Monoclonal Antibody, Unconjugated, Clone MMP2/2C1 from ABR-Affinity BioReagents
Rabbit Anti-T-box 6 Monoclonal Antibody, Unconjugated, Clone PADZMD.501 from Invitrogen
RSK2 siRNA siAb™ Assay Kit from Upstate
TriContinentMultiWash III from Femto Scientific
Biology Products: